Key result
This editorial discusses recent research identifying the ZFHX3 gene and its variants on chromosome 16q22 as a causal locus for atrial fibrillation susceptibility.
This editorial highlights the importance of moving from GWAS loci identification to understanding the functional mechanisms of genes like ZFHX3 in atrial fibrillation.
Genetics significantly influence susceptibility to atrial fibrillation (AF).Individuals with first-degree relatives under 60 years old with AF have ~5-times higher risk 1 with heritability estimated at 22%. 2 Genetic burden can be divided into two main categories: rare variants with strong effects, often due to loss of function mutations, and common variants (most often single nucleotide polymorphisms, SNPs) that can additively increase AF susceptibility.Common AF associated variants are identified by genome wide association studies (GWAS).The first published GWAS of AF in 2007 reported SNPs on 4q25 near PITX2 1 .In 2010 variants near ZHFX3 were identified. 2 With increasing cohort size, over 100 AF risk loci have now been identified.3 However, despite advancements in genomics, our understanding of the pathological mechanisms of AF remains nebulous.Polygenic risk scores for AF, using tens to millions of common variants, estimate that individuals in the top percentile have 4.6-fold increased risk of AF. 4 Exome sequencing in ~43000 UK Biobank subjects revealed that common variants explain >20-fold more of the AF variance than the rare variants.5 Thus, GWAS identify the loci responsible for most of the population-attributable genetic risk for AF.GWAS loci, using Manhattan plots, display variants at each locus with ascending significance by p-value.Most of these variants are a result of linkage disequilibrium (LD), implying they're often inherited together from ancestral chromosomes.However, discovering these loci is just the first step in the arduous tasks of identifying the responsible gene, variant(s), and mechanism for disease association.In this issue of Circulation Research, Jameson, Ellinor and colleagues 6 have performed just these tasks, focusing on the second most significant locus associated with AF, on chromosome 16q22 (Figure).The lead AF-associated SNP at this locus, rs2106261, resides in ZFHX3 gene's intron, but that is insufficient to conclude ZFHX3 as the causal gene.For example, a common SNP for coronary artery disease, located in an intron of PHACTR1, regulates the expression of a gene, EDN1 encoding endothelin-1, which is approximately 600 kb away.7 The prime hypothesis is that most GWAS variants are regulatory variants
No takes yet. Share an insight, caveat, or question.
Wass et al. (2023) conducted an editorial in Atrial fibrillation. ZFHX3 gene variants was evaluated. This editorial discusses recent research identifying the ZFHX3 gene and its variants on chromosome 16q22 as a causal locus for atrial fibrillation susceptibility.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: